Form 4: Core Labs CEO Vests Performance Shares, Boosts Stake

Core Laboratories Inc. CEO Lawrence Bruno vested 180,722 performance shares after the company exceeded return on invested capital targets, increasing his direct ownership.

Summary

• Lawrence Bruno, Chairman and CEO of Core Laboratories Inc. (CLB), vested 180,722 performance shares on December 31, 2025, which were initially awarded in February 2023.
• The vesting occurred because Core Laboratories Inc. achieved the 68th percentile in return on invested capital among its Bloomberg Peer Group at the conclusion of the performance period.
• The performance criteria for these shares were satisfied at 116.5% of the target award level.
• Concurrently, 112,681 shares of common stock were disposed of at a price of $16.03 per share on the same date, likely for tax withholding purposes related to the vesting.
• These transactions resulted in a net increase of 68,041 shares in Lawrence Bruno's direct beneficial ownership, bringing his total to 370,119 shares of common stock.

Sentiment

Score: 8

Explanation: The vesting of performance shares at 116.5% of target, driven by strong return on invested capital performance (68th percentile among peers), indicates robust company execution and positive alignment of executive incentives with shareholder value. The disposition of shares is a standard tax-related event.

Positives

• Performance criteria for restricted shares were satisfied at 116.5% of the target award level, indicating strong company performance.
• The company achieved the 68th percentile in return on invested capital among its Bloomberg Peer Group, demonstrating strong relative performance.
• Lawrence Bruno's direct beneficial ownership increased by a net of 68,041 shares, aligning executive incentives with shareholder value.

Negatives

• 112,681 shares were disposed of at $16.03 per share, which, while a common practice for tax withholding upon vesting, represents a reduction in the total shares received from the award.

Future Outlook

NA

Management Comments

• The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025.
• Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025.

Industry Context

The achievement of the 68th percentile in return on invested capital against a Bloomberg Peer Group suggests Core Laboratories Inc. is performing well relative to its industry competitors, indicating effective capital deployment and operational efficiency within the energy services sector.

Comparison to Industry Standards

• Core Laboratories Inc. achieved the 68th percentile in return on invested capital among its Bloomberg Peer Group, indicating above-average performance in capital efficiency compared to industry peers.
• The satisfaction of performance criteria at 116.5% of the target award level demonstrates strong execution against internal and potentially external benchmarks for executive compensation.

Stakeholder Impact

• Shareholders: Positive signal regarding management's performance and alignment of interests, as the CEO's equity stake increased due to exceeding performance targets.
• Employees: May indicate a strong performance culture within the company.

Key Dates

Recommendation

The vesting of performance shares at an above-target level, driven by strong return on invested capital relative to peers, is a positive indicator of management effectiveness and company performance. This aligns executive incentives with shareholder value creation. However, this single Form 4 filing, while positive, does not provide sufficient comprehensive financial data to warrant an immediate 'buy' or 'strong buy' recommendation without further analysis of the company's broader financial health, market conditions, and future outlook. It reinforces a 'hold' position for existing investors and suggests a positive signal for those considering the stock.

Keywords

Core Laboratories, CLB, Lawrence Bruno, CEO, Performance Shares, Stock Vesting, Insider Trading, SEC Form 4, Return on Invested Capital, Executive Compensation